Provider
QP87-24 MHCP Pharmacy Benefit Exclusion for Aurlumyn™, MydCombi™, paclitaxel protein-bound particles, Pavblu™ and Vyloy®
Program effective Date: Dec 11, 2024
Program effective Date: Dec 11, 2024
Program effective Date: Dec 11, 2024
Program effective Date: Dec 11, 2024
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2025
Prior Authorization
Program effective Date: Jan 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2025